Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Gene therapy for lysosomal storage disease: A no-brainer?

Transplants of fibroblasts secreting high levels of β-glucuronidase decrease lesions in the brains of mice with Sly syndrome, a lysososmal storage disease (771–774).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sly, W.S., Quinton, B.A., McAlister, W.H. & Rimoin, D.L. β-glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J. Pediatr. 82, 249–257 (1973).

    Article  CAS  PubMed  Google Scholar 

  2. Neufeld, E.F. & Muenzer, J. The mucopolysacchari-doses. In The Metabolic and Molecular Bases of Inherited Disease (eds. Scriver, C. R. Beaudet, A. L, Sly, W.S. & Valle, D). 2465–2494 (McGraw-Hill, New York, 1995).

    Google Scholar 

  3. Taylor, R.M. & Wolfe, J.H. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fi broblasts secreting high levels of β-glucuronidase. Nature Med. 3, 771–774 (1997).

    Article  CAS  PubMed  Google Scholar 

  4. Birkenmeier, E.H. et al. Murine mucopolysacchari dosis VII: Characterization of a mouse with β-glucuronidase deficiency. J. Clin Invest. 83, 1258–1266 (1989).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Birkenmeier, E.H. et al. Increased lifespan and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 78, 3081–3092 (1991).

    CAS  PubMed  Google Scholar 

  6. Sands, M.S. et al. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J. Clin. Invest. 93, 2324–2331 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sands, M.S. et al. Murine mucopolysaccharidosis type VII: Long-term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. J. Clin. Invest. 99, 1596–1605 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sly, W.S. Gene therapy on the Sly. Nature Genet. 4, 105–106 (1993).

    Article  CAS  PubMed  Google Scholar 

  9. Li, T. & Davidson, B.L. Phenotypic correction in retinal pigment epithelium in murine mucopolysac charidosis VII by adenovirus-mediated gene transfer. Proc Natl. Acad. Sci. U.S.A. 92, 7700–7704 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ohashi, T. et al. Adenovirus-mediated gene transfer and expression of human β-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice. Proc. Natl. Acad. Sci. U.S.A. 94, 1287–1292 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sly, W., Vogler, C. Gene therapy for lysosomal storage disease: A no-brainer?. Nat Med 3, 719–720 (1997). https://doi.org/10.1038/nm0797-719

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0797-719

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing